Switzerland - Hospital Average Length of Stay for Carcinoma in Situ
Since 2014, Switzerland Hospital Average Length of Stay for Carcinoma in Situ decreased by 2.3% year on year. In 2019, the country was number 17 comparing other countries in Hospital Average Length of Stay for Carcinoma in Situ with 3.3 Days. Switzerland is overtaken by Austria, which was ranked number 16 with 3.7 Days and is followed by Lithuania at 3.2 Days. South Korea topped the ranking with 7.5 Days in 2019, a decrease of 2.6% compared to 2018. Slovakia, Latvia and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland witnessed the best average annual growth at +10.6% per year, while New Zealand was the worst growing country at -8% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 3.30 |
| 2018 | 3.50 |
| 2017 | 3.30 |
| 2016 | 3.30 |
| 2015 | 3.40 |
Download all data from 2002 to 2019
How does Switzerland rank in Hospital Average Length of Stay for Carcinoma in Situ?
| # | 33 Countries | Days | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
South Korea
|
7.50 | 2019 | -2.6 % | +0.8 % | View data | |
| 2 |
#2
Slovakia
|
5.40 | 2019 | +0.0 % | +0.4 % | View data | |
| 16 |
#16
Austria
|
3.70 | 2019 | -7.5 % | +2.3 % | View data | |
| 17 |
#17
Switzerland
|
3.30 | 2019 | -5.7 % | -2.3 % | View data | |
| 18 |
#18
Ireland
|
3.20 | 2019 | +0.0 % | -6.6 % | View data | |